Practice guidelines for the management of bacterial meningitis.
By A. Tunkel, B. Hartman, S. Kaplan, B. Kaufman, K. Roos, W. Scheld, R. Whitley. Clinical Infectious Diseases, 2004
2,127 citations recorded by the source corpus.
Subfields: Epidemiology, Microbiology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/24df371f96da07be129d74121fb9097794109c5d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Microbiology
In Public Health, Environmental and Occupational Health
Citations in the corpus
- General Principles of Antimicrobial Therapy (2011, background): “For example, in an otherwise healthy young adult with suspected bacterial meningitis who is seen in the emergency department, the most likely pathogens would be and , and thus a combination of a third-generation cephalosporin (ceftriaxone) plus vancomycin would be recommended as empiric therapy.(5) ”
- Acinetobacter baumannii: Emergence of a Successful Pathogen (2008, background): “Dosing varies greatly between studies, but according to the Infectious Diseases Society of America, 5 mg of polymyxin B or 10 mg of colistin daily is recommended for adults (553).”
- A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a (2013, background): “Bacterial antigen testing on CSF is not recommended but may have some value in patients who received therapy prior to specimen collection with negative Gram stain and negative culture results [14].”
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010, background): “Therefore, empirical therapy should include vancomycin, an expanded-spectrum cephalosporin, and ampicillin (311, 320).”
- The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. (2008, neutral): “Other empirical antimicrobial agents should be initiated on the basis of specific epidemiologic or clinical factors (tables 2 and 3), including appropriate therapy for presumed bacterial meningitis if clinically indicated [70].”
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections (2010, background): “pneumoniae meningitis are scarce, some authors recommended that in areas with high rates of occurrence of penicillin-resistant pneumococcal strains, the combination of ceftriaxone plus rifampin instead of vancomycin should be preferred, or rifampin, vancomycin, and ceftriaxone should be administered”